EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study

Maribel Del Olmo-García, Lorena Hernandez-Rienda, Rocio Garcia-Carbonero iD, Jorge Hernando, Ana Custodio, Beatriz Anton-Pascual, Marta Gomez, Samara Palma Milla, Lorena Suarez, Marta Bellver, Vicente Alonso, Raquel Serrano und 13 weitere

The Oncologist · 2025

DOI: 10.1093/oncolo/oyae343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Maribel Del Olmo-García und 24 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Department, Endocrinology, Nutrition and Diet Therapy Research Unit, University and Polytechnic Hospital La Fe, Valencia,…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Nutritional Status, Pancreatic Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GETNE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have impaired nutritional and physical performance due to the cancer pathophysiology and its treatment. The NUTRIGETNE study sought to characterize the nutritional status of patients with advanced GEP-NENs in Spain. This is a cross-sectional study that included patients with advanced GEP-NENs receiving active oncological treatment. Patients had a complete physical examination, anthropometry, bioelectrical impedance, dynamometry, laboratory analysis, and a comprehensive nutritional risk assessment. Malnutrition was defined according to Global Leadership Initiative on Malnutrition (GLIM) criteria. The study included 399 patients out of the 400 planned (Pearson’s χ2; α 0.05). Median age was 62 years (22-83). Tumors most commonly originated in the small intestine (43.9%) and the pancreas (41.6%), 94.7% were metastatic, and 36.7%, 49.4%, and 12.5% were G1, G2, and G3, respectively. Malnutrition prevalence was 61.9% (25.8% moderate; 36.1% severe), mainly due to low muscle mass (50.9%), which was the most prevalent GLIM phenotypic criteria. Moreover, malnutrition showed a correlation with decreased hand grip strength (mean 23 vs 31.9 kg; P <.001) and phase angle (median 5o vs 5.6o; P <.001). The prevalence of sarcopenia was 15%. Malnutrition was more frequent in patients with diabetes (74.4% vs 56.7%; P <.001), NECs (82.1% vs 60.3%; P =.062), and in those treated with chemotherapy (71.2% vs 59.7%; P =.058), whereas it did not correlate with tumor origin (P =.507), histological grade (P =.781), or functionality (P =.465). Malnutrition was correlated to body mass index (BMI) (P =.015), although it was also diagnosed in a high proportion of patients with no weight loss (63%, 54.1%, and 65.1% of patients with normal BMI, overweight, and obesity, respectively). Cachexia was present in 109 (27.3%) patients. Malnutrition is very prevalent and commonly underdiagnosed in patients with GEP-NENs. It is associated with sarcopenia and a worse QoL, requiring a multifactorial nutritional assessment. Certain factors such as the presence of diabetes may require closer monitoring due to a higher risk of malnutrition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsNutritional StatusPancreatic NeoplasmsStomach NeoplasmsQuality of LifeIntestinal NeoplasmsMalnutritionHumansFemaleMaleMiddle AgedAgedSpainAdultCross-Sectional StudiesAged, 80 and overYoung Adult

Stichwörter der Autor:innen

gastroenteropancreaticmalnutritionneuroendocrine neoplasmsnutritional statussarcopenia

Autor:innen und Institutionen

  • Endocrinology and Nutrition Department, Endocrinology, Nutrition and Diet Therapy Research Unit, University and Polytechnic Hospital La Fe, Valencia, 46026, Spain.
  • Departamento de Medicina, Universidad de Valencia, Valencia, 46010, Spain.
  • Medical Oncology Department, Hospital Universitario 12 de Octubre, Imas12, Facultad de Medicina, UCM, Madrid, 28041, Spain.
  • Medical Oncology Department, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain.
  • Medical Oncology Department, Hospital Universitario La Paz, Instituto de Investigación Biomédica Hospital Universitario La Paz (IdiPAZ), Madrid, 28046, Spain.
  • Nutritional Support Unit, Vall Hebron University Hospital, Barcelona, 08035, Spain.

ORCID-Profile: Rocio Garcia-Carbonero, Beatriz Febrero, María Argente Pla

Förderung

  • GETNE

Zitieren

APA

Del Olmo-García, M., Hernandez-Rienda, L., Garcia-Carbonero, R., Hernando, J., Custodio, A., Anton-Pascual, B., Gomez, M., Palma Milla, S., Suarez, L., Bellver, M., Alonso, V., Serrano, R., Valdés, N., Melian, M., Febrero, B., Sampedro-Nuñez, M. A., Biarnes, J., Díaz-Pérez, J. Á., Molina-Cerrillo, J., …, & NUTRIGETNE Group (2025). Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study. The Oncologist. https://doi.org/10.1093/oncolo/oyae343

Vancouver

Del Olmo-García M, Hernandez-Rienda L, Garcia-Carbonero R, Hernando J, Custodio A, Anton-Pascual B, et al. Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study. The Oncologist. 2025. doi:10.1093/oncolo/oyae343

BibTeX
@article{DelOlmoGarca2025,
  author = {Del Olmo-García, Maribel and Hernandez-Rienda, Lorena and Garcia-Carbonero, Rocio and Hernando, Jorge and Custodio, Ana and Anton-Pascual, Beatriz and Gomez, Marta and Palma Milla, Samara and Suarez, Lorena and Bellver, Marta and Alonso, Vicente and Serrano, Raquel and Valdés, Nuria and Melian, Marcos and Febrero, Beatriz and Sampedro-Nuñez, Miguel Antonio and Biarnes, Josefina and Díaz-Pérez, José Ángel and Molina-Cerrillo, Javier and Lopez, Carlos and Martínez Olmos, Miguel Ángel and Merino-Torres, Juan Francisco and Capdevila, Jaume and Argente Pla, María and NUTRIGETNE Group, NUTRIGETNE Group},
  title = {Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyae343}
}
Kostenlos starten →